• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

Introduction to tert-butyl 7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate (CAS No. 879687-92-0)

Tert-butyl 7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate, identified by the chemical compound identifier CAS No. 879687-92-0, is a specialized organic molecule that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the isoindole class, a structural motif known for its diverse biological activities and potential applications in drug development. The unique arrangement of functional groups in its molecular structure, including the tert-butyl substituent and the 7-oxo moiety, contributes to its distinctive chemical properties and reactivity patterns.

The synthesis and characterization of tert-butyl 7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate have been subjects of extensive study due to its relevance in designing novel therapeutic agents. The presence of the hexahydroisoindole core suggests potential interactions with biological targets such as enzymes and receptors, which are pivotal in modulating various physiological processes. This compound’s structural features make it a valuable intermediate in the synthesis of more complex molecules with enhanced pharmacological profiles.

In recent years, there has been a growing interest in isoindole derivatives as pharmacophores due to their ability to exhibit a wide range of biological activities. For instance, studies have demonstrated that isoindole-based compounds can serve as potent inhibitors of certain enzymes involved in inflammatory pathways and cancer progression. The tert-butyl group in tert-butyl 7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate not only enhances the lipophilicity of the molecule but also influences its metabolic stability and binding affinity to biological targets.

One of the most compelling aspects of this compound is its potential application in the development of next-generation therapeutics. Researchers have been exploring its utility as a precursor for designing small-molecule drugs that can selectively target specific diseases. The 7-oxo group within the isoindole framework is particularly noteworthy, as it has been shown to modulate the electronic properties of the molecule, thereby affecting its interactions with biological systems. This feature makes it an attractive candidate for further investigation in drug discovery initiatives.

The chemical synthesis of tert-butyl 7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate involves multi-step reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies have been employed to optimize the process, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions. These techniques not only facilitate the introduction of functional groups but also enhance the overall efficiency of the synthetic route.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the binding interactions between tert-butyl 7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate and potential biological targets. These simulations have provided insights into how structural modifications can influence pharmacological activity. For example, alterations in the position or size of substituents such as the tert-butyl group can significantly impact binding affinity and selectivity.

The pharmacokinetic properties of this compound are also under scrutiny to assess its suitability for clinical applications. Studies have focused on evaluating its solubility profile、metabolic stability、and excretion pathways. These parameters are critical for determining whether it can be developed into a viable drug candidate that meets regulatory standards for safety and efficacy.

In conclusion,tert-butyl 7-oxyloxyloxyloxyloxyloxyhexahydroisoindolcarboxylic acid (CAS No. 879687)-92-a) represents a promising entity in pharmaceutical research due to its unique structural features and potential biological activities。 Further exploration into its synthetic pathways、pharmacological effects、and clinical applicability will continue to drive advancements in drug development。 As our understanding of molecular interactions evolves，this compound may emerge as a key component in novel therapeutic strategies aimed at addressing various diseases.

• 1251570-84-9((s)-Tert-butyl 3-butyrylpyrrolidine-1-carboxylate)
• 1374673-89-8(tert-Butyl (3S)-3-acetylpyrrolidine-1-carboxylate)
• 1695673-11-0(tert-butyl 3-(2-methylpropanoyl)pyrrolidine-1-carboxylate)
• 543910-82-3(tert-butyl cis-7-oxo-3,3a,4,5,6,7a-hexahydro-1H-isoindole-2-carboxylate)
• 1251570-77-0((S)-1-Boc-3-(3-methylbutanoyl)pyrrolidine)
• 2060619-91-0(tert-butyl 6-oxo-2-azaspiro[4.5]decane-2-carboxylate)
• 858643-95-5(Tert-butyl 3-acetylpyrrolidine-1-carboxylate)
• 1517990-29-2(3-Propionyl-pyrrolidine-1-carboxylic acid tert-butyl ester)
• 1374673-69-4(Tert-Butyl (3R)-3-acetylpyrrolidine-1-carboxylate)
• 2062661-45-2(tert-butyl (3S,4S)-3-acetyl-4-methylpyrrolidine-1-carboxylate)